Vaxxinity, Inc. – NASDAQ:VAXX
Founder-led company
Vaxxinity stock price today
$0
-0.00
-50%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Vaxxinity stock price monthly change
-100.00%
month
Vaxxinity stock price quarterly change
-100.00%
quarter
Vaxxinity stock price yearly change
-100.00%
year
Vaxxinity key metrics
Market Cap | 50.71K |
Enterprise value | 178.53M |
P/E | -3.86 |
EV/Sales | 405.75 |
EV/EBITDA | -3.54 |
Price/Sales | 629.74 |
Price/Book | 2.84 |
PEG ratio | 0.01 |
EPS | -0.44 |
Revenue | N/A |
EBITDA | -54.43M |
Income | -56.92M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -11641.59% |
Oper. margin | -11326.36% |
Gross margin | -390% |
EBIT margin | -11326.36% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeVaxxinity stock price history
Vaxxinity stock forecast
Vaxxinity financial statements
| Mar 2023 | 0 | -18.40M | |
|---|---|---|---|
| Jun 2023 | 0 | -13.97M | |
| Sep 2023 | 0 | -13.14M | |
| Dec 2023 | 0 | -11.39M |
| 2027 | 0 | -51.86M |
|---|
Analysts Price target
Financials & Ratios estimates
| 2024-05-14 | -0.1 | -0.15 |
|---|
| Mar 2023 | 85531000 | 39.39M | 46.06% |
|---|---|---|---|
| Jun 2023 | 71367000 | 36.35M | 50.94% |
| Sep 2023 | 57479000 | 33.77M | 58.76% |
| Dec 2023 | 44353000 | 30.94M | 69.77% |
| Mar 2023 | -20.05M | 8.74M | -574K |
|---|---|---|---|
| Jun 2023 | -12.15M | 26.61M | 126K |
| Sep 2023 | -13.18M | -6.09M | -379K |
| Dec 2023 | -11.84M | -407K | -313K |
Vaxxinity alternative data
| Aug 2023 | 87 |
|---|---|
| Sep 2023 | 87 |
| Oct 2023 | 87 |
| Nov 2023 | 87 |
| Dec 2023 | 87 |
| Jan 2024 | 87 |
| Feb 2024 | 87 |
| Mar 2024 | 87 |
| Apr 2024 | 87 |
| May 2024 | 57 |
| Jun 2024 | 57 |
| Jul 2024 | 57 |
Vaxxinity other data
1.07%
-16.94%
of VAXX is owned by hedge funds
1.34M
-21.34M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2022 | 0 | 348548 |
| Jan 2023 | 0 | 500692 |
| Sep 2023 | 0 | 96936 |
| Insider | Compensation |
|---|---|
Ms. Mei Mei Hu J.D. (1983) Co-Founder, Pres, Chief Executive Officer & Director | $347,700 |
Mr. Louis Garfield Reese IV (1982) Co-Founder & Executive Chairman | $347,690 |
| Dr. Farshad Guirakhoo Ph.D. (1953) Chief Scientific Officer | $321,390 |
-
What's the price of Vaxxinity stock today?
One share of Vaxxinity stock can currently be purchased for approximately $0.
-
When is Vaxxinity's next earnings date?
Unfortunately, Vaxxinity's (VAXX) next earnings date is currently unknown.
-
Does Vaxxinity pay dividends?
No, Vaxxinity does not pay dividends.
-
How much money does Vaxxinity make?
Vaxxinity has a market capitalization of 50.71K. Vaxxinity made a loss 56.93K US dollars in net income (profit) last year or -$0.15 on an earnings per share basis.
-
What is Vaxxinity's stock symbol?
Vaxxinity, Inc. is traded on the NASDAQ under the ticker symbol "VAXX".
-
What is Vaxxinity's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Vaxxinity?
Shares of Vaxxinity can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Vaxxinity's key executives?
Vaxxinity's management team includes the following people:
- Ms. Mei Mei Hu J.D. Co-Founder, Pres, Chief Executive Officer & Director(age: 42, pay: $347,700)
- Mr. Louis Garfield Reese IV Co-Founder & Executive Chairman(age: 43, pay: $347,690)
- Dr. Farshad Guirakhoo Ph.D. Chief Scientific Officer(age: 72, pay: $321,390)
-
Is Vaxxinity founder-led company?
Yes, Vaxxinity is a company led by its founders Ms. Mei Mei Hu J.D. and Mr. Louis Garfield Reese IV.
-
How many employees does Vaxxinity have?
As Jul 2024, Vaxxinity employs 57 workers, which is 34% less then previous quarter.
-
When Vaxxinity went public?
Vaxxinity, Inc. is publicly traded company for more then 3 years since IPO on 11 Nov 2021.
-
What is Vaxxinity's official website?
The official website for Vaxxinity is vaxxinity.com.
-
Where are Vaxxinity's headquarters?
Vaxxinity is headquartered at 1717 Main Street, Dallas, TX.
-
How can i contact Vaxxinity?
Vaxxinity's mailing address is 1717 Main Street, Dallas, TX and company can be reached via phone at +254 24 45739.
Vaxxinity company profile:
Vaxxinity, Inc.
vaxxinity.comExchange:
NASDAQ
Full time employees:
57
Industry:
Biotechnology
Sector:
Healthcare
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy that is in phase 1 clinical trial; and an anti-tau product candidate for various neurodegenerative conditions, including AD. It is also developing UB-313 that targets calcitonin gene-related peptide to fight migraines; anti-PCSK9 that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; and UB-612 for neutralizing the SARS-CoV-2 virus, which is in phase 3 clinical trial. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas.
1717 Main Street
Dallas, TX 75201
Dallas, TX 75201
CIK: 0001851657
ISIN: US92244V1044
CUSIP: 92244V104
